Real-time Stock quotes, portfolio, LIVE TV and more.
37.15 (1.84%)
34.9 (1.73%) 5.55 pm | 22 May 2013 | Source: CNBC-TV18
Ashish Chaturmohta of Fortune Equity Brokers is of the view that Dr Reddys Laboratories can cross Rs 2100 and can see a move towards Rs 2150 in this s...
2.23 pm | 22 May 2013 | Source: CNBC-TV18
Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...
12.17 pm | 22 May 2013 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com feels Dr Reddys Laboratories is heading for deep correction. "It has broken down from a clear trading range on th...
4.53 pm | 17 May 2013 | Source: CNBC-TV18
Aashish Tater, Head of Research, Fortunewizard.com is of the view that Lupin, Sun Pharmaceutical Industries and Dr Reddys Laboratories are safe bets. ...
4.45 pm | 17 May 2013 | Source: CNBC-TV18
Aashish Tater, Head of Research, Fortunewizard.com feels that there is lot of money that can be made in Sun Pharma Advance Research Company....
10.38 am | 15 May 2013 | Source: CNBC-TV18
For the index to touch 6100, Reliance Industries, Infosys and TCS will have to perform, says Vineet Bhatnagar opf Phillip Capital. He is bullish on p...
6.10 pm | 14 May 2013 | Source: CNBC-TV18
One can hold Dr Reddys Laboratories, says Prakash Diwan, Chief Portfolio Strategist of Prakash Diwan's Wealth Circle, ECR. ...
10.19 am | 13 May 2013 | Source: CNBC-TV18
Maruti is a play on the yen more than anything, says Sanjeev Prasad of Kotak Institutional Equities. He is bearish on FMCG stocks, and says will not b...
4.38 pm | 09 May 2013 | Source: CNBC-TV18
VK Sharma of HDFC Securities said one could consider buying Dr Reddys Labs 2000 Call, with a stop loss of Rs 40....
3.36 pm | 02 May 2013 | Source: Reuters
Nomura Equity Research is "overweight" on rate cyclicals and defensive growth plays but remains "underweight" on domestic growth cyclicals....
1.51 pm | 30 Apr 2013 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that, one should buy Dr Reddys Laboratories....
6.11 pm | 29 Apr 2013 | Source: CNBC-TV18
Dr Reddys Labs may see 5-7% upside, says Vishal B Malkan, malkansview.com....
9.11 am | 22 Apr 2013 | Source: CNBC-TV18
On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Securities, Vikrant Jadeja, vibranttrades.com and Vishal Malkan, malkansview.com, pl...
2.16 pm | 13 Apr 2013 | Source: CNBC-TV18
Buying opportunities is seen in HPCL and Dr Reddys Labs at current levels, says Sudarshan Sukhani, s2analytics.com....